Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sinusitis | 6 | 2023 | 60 | 1.780 |
Why?
|
| Free Tissue Flaps | 5 | 2023 | 56 | 1.610 |
Why?
|
| Rhinitis | 3 | 2022 | 33 | 1.180 |
Why?
|
| Paranasal Sinuses | 2 | 2023 | 25 | 1.000 |
Why?
|
| Intraoperative Care | 1 | 2021 | 57 | 0.820 |
Why?
|
| Hypotension | 1 | 2021 | 67 | 0.780 |
Why?
|
| Vasoconstrictor Agents | 1 | 2021 | 88 | 0.770 |
Why?
|
| Intraoperative Complications | 1 | 2021 | 125 | 0.750 |
Why?
|
| Reoperation | 1 | 2021 | 454 | 0.710 |
Why?
|
| Head and Neck Neoplasms | 4 | 2023 | 335 | 0.650 |
Why?
|
| Retrospective Studies | 16 | 2023 | 6432 | 0.480 |
Why?
|
| Cerebrospinal Fluid Rhinorrhea | 2 | 2022 | 8 | 0.440 |
Why?
|
| Nasal Polyps | 2 | 2022 | 9 | 0.440 |
Why?
|
| Chronic Disease | 4 | 2023 | 612 | 0.290 |
Why?
|
| Ambulatory Care Facilities | 2 | 2023 | 136 | 0.240 |
Why?
|
| Endoscopy | 2 | 2022 | 131 | 0.230 |
Why?
|
| Mandibular Reconstruction | 1 | 2023 | 10 | 0.230 |
Why?
|
| Treatment Outcome | 4 | 2022 | 5604 | 0.230 |
Why?
|
| Scapula | 1 | 2023 | 19 | 0.230 |
Why?
|
| Maxillary Sinusitis | 1 | 2023 | 13 | 0.230 |
Why?
|
| Nasal Obstruction | 1 | 2022 | 16 | 0.220 |
Why?
|
| Surgical Flaps | 1 | 2023 | 135 | 0.210 |
Why?
|
| Humans | 19 | 2023 | 54246 | 0.210 |
Why?
|
| Head | 1 | 2021 | 77 | 0.200 |
Why?
|
| Infusions, Intravenous | 1 | 2021 | 231 | 0.200 |
Why?
|
| Neck Dissection | 1 | 2021 | 43 | 0.200 |
Why?
|
| Velopharyngeal Insufficiency | 1 | 2021 | 21 | 0.200 |
Why?
|
| Eustachian Tube | 1 | 2021 | 15 | 0.190 |
Why?
|
| Neck | 1 | 2021 | 116 | 0.190 |
Why?
|
| Drug Administration Schedule | 1 | 2021 | 401 | 0.190 |
Why?
|
| Robotics | 1 | 2021 | 45 | 0.190 |
Why?
|
| Tonsillectomy | 1 | 2021 | 49 | 0.190 |
Why?
|
| Otolaryngology | 1 | 2021 | 58 | 0.190 |
Why?
|
| Quality of Life | 3 | 2022 | 922 | 0.190 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2021 | 52 | 0.190 |
Why?
|
| Morbidity | 1 | 2021 | 149 | 0.190 |
Why?
|
| Venous Thrombosis | 1 | 2021 | 102 | 0.190 |
Why?
|
| Cleft Palate | 1 | 2021 | 72 | 0.180 |
Why?
|
| Odds Ratio | 1 | 2021 | 604 | 0.180 |
Why?
|
| Inpatients | 1 | 2021 | 204 | 0.170 |
Why?
|
| Diabetes Mellitus | 1 | 2022 | 307 | 0.160 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2022 | 384 | 0.160 |
Why?
|
| Aged | 2 | 2021 | 10041 | 0.150 |
Why?
|
| Heart Defects, Congenital | 1 | 2023 | 608 | 0.150 |
Why?
|
| Aged, 80 and over | 2 | 2022 | 3429 | 0.150 |
Why?
|
| Adult | 3 | 2021 | 14182 | 0.140 |
Why?
|
| Middle Aged | 4 | 2023 | 13070 | 0.130 |
Why?
|
| Male | 5 | 2023 | 27312 | 0.100 |
Why?
|
| Ambulatory Care | 2 | 2023 | 229 | 0.100 |
Why?
|
| Postoperative Complications | 3 | 2022 | 1033 | 0.090 |
Why?
|
| Female | 4 | 2023 | 28418 | 0.090 |
Why?
|
| Quality Improvement | 2 | 2021 | 245 | 0.080 |
Why?
|
| Child | 4 | 2021 | 7337 | 0.080 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2023 | 1213 | 0.080 |
Why?
|
| Prospective Studies | 2 | 2021 | 2604 | 0.060 |
Why?
|
| Facial Bones | 1 | 2023 | 22 | 0.060 |
Why?
|
| Maxillary Sinus | 1 | 2023 | 8 | 0.060 |
Why?
|
| Forearm | 1 | 2023 | 41 | 0.060 |
Why?
|
| Facial Pain | 1 | 2022 | 14 | 0.050 |
Why?
|
| Nose | 1 | 2022 | 42 | 0.050 |
Why?
|
| Albumins | 1 | 2022 | 38 | 0.050 |
Why?
|
| Microsurgery | 1 | 2021 | 35 | 0.050 |
Why?
|
| Anastomosis, Surgical | 1 | 2021 | 72 | 0.050 |
Why?
|
| Glossectomy | 1 | 2021 | 6 | 0.050 |
Why?
|
| Salvage Therapy | 1 | 2022 | 145 | 0.050 |
Why?
|
| Tongue | 1 | 2021 | 41 | 0.050 |
Why?
|
| Pharynx | 1 | 2021 | 39 | 0.050 |
Why?
|
| Acute Disease | 1 | 2022 | 403 | 0.050 |
Why?
|
| Nausea | 1 | 2021 | 52 | 0.050 |
Why?
|
| Operating Rooms | 1 | 2021 | 40 | 0.050 |
Why?
|
| Efficiency, Organizational | 1 | 2021 | 53 | 0.050 |
Why?
|
| Arteries | 1 | 2021 | 101 | 0.050 |
Why?
|
| Vomiting | 1 | 2021 | 73 | 0.050 |
Why?
|
| Pain, Postoperative | 1 | 2021 | 161 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 1304 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2022 | 488 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2022 | 1228 | 0.040 |
Why?
|
| Dexamethasone | 1 | 2021 | 435 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2023 | 2387 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2022 | 644 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2022 | 1361 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2021 | 4146 | 0.030 |
Why?
|
| Young Adult | 1 | 2021 | 4308 | 0.020 |
Why?
|
| Adolescent | 1 | 2021 | 6885 | 0.020 |
Why?
|